132 related articles for article (PubMed ID: 14529353)
41. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
42. Binding proteins internalized by PTD-fused ligands allow the intracellular sequestration of selected targets by ligand exchange.
Moosmeier MA; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
Int J Mol Med; 2010 Apr; 25(4):557-64. PubMed ID: 20198304
[TBL] [Abstract][Full Text] [Related]
43. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.
De Coupade C; Fittipaldi A; Chagnas V; Michel M; Carlier S; Tasciotti E; Darmon A; Ravel D; Kearsey J; Giacca M; Cailler F
Biochem J; 2005 Sep; 390(Pt 2):407-18. PubMed ID: 15859953
[TBL] [Abstract][Full Text] [Related]
44. PTD/CPP peptide-mediated delivery of siRNAs.
Presente A; Dowdy SF
Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
[TBL] [Abstract][Full Text] [Related]
45. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
Kaplan IM; Wadia JS; Dowdy SF
J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
[TBL] [Abstract][Full Text] [Related]
46. [Protein transduction by poly-arginine].
Matsui H; Tomizawa K; Matsushita M
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):435-9. PubMed ID: 12835537
[TBL] [Abstract][Full Text] [Related]
47. Biological applications of protein transduction technology.
Kabouridis PS
Trends Biotechnol; 2003 Nov; 21(11):498-503. PubMed ID: 14573363
[TBL] [Abstract][Full Text] [Related]
48. siRNA delivery using peptide transduction domains.
Eguchi A; Dowdy SF
Trends Pharmacol Sci; 2009 Jul; 30(7):341-5. PubMed ID: 19545914
[TBL] [Abstract][Full Text] [Related]
49. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E
Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307
[TBL] [Abstract][Full Text] [Related]
50. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
51. Peptide-based nanoparticle for ex vivo and in vivo drug delivery.
Crombez L; Morris MC; Deshayes S; Heitz F; Divita G
Curr Pharm Des; 2008; 14(34):3656-65. PubMed ID: 19075741
[TBL] [Abstract][Full Text] [Related]
52. CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.
Kurzeder C; Koppold B; Sauer G; Pabst S; Kreienberg R; Deissler H
Int J Mol Med; 2007 Feb; 19(2):325-33. PubMed ID: 17203208
[TBL] [Abstract][Full Text] [Related]
53. Modulation of cellular function by TAT mediated transduction of full length proteins.
Wadia JS; Dowdy SF
Curr Protein Pept Sci; 2003 Apr; 4(2):97-104. PubMed ID: 12678849
[TBL] [Abstract][Full Text] [Related]
54. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.
Kallunki P; Tryggvason K
J Cell Biol; 1992 Jan; 116(2):559-71. PubMed ID: 1730768
[TBL] [Abstract][Full Text] [Related]
55. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.
Ho A; Schwarze SR; Mermelstein SJ; Waksman G; Dowdy SF
Cancer Res; 2001 Jan; 61(2):474-7. PubMed ID: 11212234
[TBL] [Abstract][Full Text] [Related]
56. The importance of valency in enhancing the import and cell routing potential of protein transduction domain-containing molecules.
Sung M; Poon GM; Gariépy J
Biochim Biophys Acta; 2006 Mar; 1758(3):355-63. PubMed ID: 16442074
[TBL] [Abstract][Full Text] [Related]
57. Heparan sulfate proteoglycan as a plasma membrane carrier.
Belting M
Trends Biochem Sci; 2003 Mar; 28(3):145-51. PubMed ID: 12633994
[TBL] [Abstract][Full Text] [Related]
58. Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides.
Hou YW; Chan MH; Hsu HR; Liu BR; Chen CP; Chen HH; Lee HJ
Exp Dermatol; 2007 Dec; 16(12):999-1006. PubMed ID: 18031459
[TBL] [Abstract][Full Text] [Related]
59. Preparation and functional analysis of recombinant protein transduction domain-metallothionein fusion proteins.
Lim KS; Won YW; Park YS; Kim YH
Biochimie; 2010 Aug; 92(8):964-70. PubMed ID: 20403412
[TBL] [Abstract][Full Text] [Related]
60. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.
Snyder EL; Dowdy SF
Expert Opin Drug Deliv; 2005 Jan; 2(1):43-51. PubMed ID: 16296734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
